An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3

Research output: Contribution to journalArticle

Abstract

Reprogrammable mouse models engineered to conditionally express Oct-4, Klf-4, Sox-2 and c-Myc (OKSM) have been instrumental in dissecting molecular events underpinning the generation of induced pluripotent stem cells. However, until now these models have been reported in the context of the m2 reverse tetracycline-controlled transactivator, which results in a low reprogramming efficiency and consequently limits the number of reprogramming intermediates that can be isolated for downstream profiling. Here, we describe an improved OKSM mouse model in the context of the reverse tetracycline-controlled transactivator 3 with enhanced reprogramming efficiency (>. 9-fold) and increased numbers of reprogramming intermediate cells albeit with similar kinetics, which we believe will facilitate mechanistic studies of the reprogramming process.
LanguageEnglish
Pages49-53
Number of pages5
JournalStem Cell Research
Volume17
Issue number1
DOIs
StatePublished - 1 Jul 2016

Cite this

@article{b06298c0735947509d122407bd915100,
title = "An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3",
abstract = "Reprogrammable mouse models engineered to conditionally express Oct-4, Klf-4, Sox-2 and c-Myc (OKSM) have been instrumental in dissecting molecular events underpinning the generation of induced pluripotent stem cells. However, until now these models have been reported in the context of the m2 reverse tetracycline-controlled transactivator, which results in a low reprogramming efficiency and consequently limits the number of reprogramming intermediates that can be isolated for downstream profiling. Here, we describe an improved OKSM mouse model in the context of the reverse tetracycline-controlled transactivator 3 with enhanced reprogramming efficiency (>. 9-fold) and increased numbers of reprogramming intermediate cells albeit with similar kinetics, which we believe will facilitate mechanistic studies of the reprogramming process.",
author = "S. Alaei and A.S Knaupp and S.M. Lim and J. Chen and M.L. Holmes and M-L Ank{\"o} and C.M. Nefzger and Polo, {J. M.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.scr.2016.05.008",
language = "English",
volume = "17",
pages = "49--53",
journal = "Stem Cell Research",
issn = "1873-5061",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3

AU - Alaei,S.

AU - Knaupp,A.S

AU - Lim,S.M.

AU - Chen,J.

AU - Holmes,M.L.

AU - Ankö,M-L

AU - Nefzger,C.M.

AU - Polo,J. M.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Reprogrammable mouse models engineered to conditionally express Oct-4, Klf-4, Sox-2 and c-Myc (OKSM) have been instrumental in dissecting molecular events underpinning the generation of induced pluripotent stem cells. However, until now these models have been reported in the context of the m2 reverse tetracycline-controlled transactivator, which results in a low reprogramming efficiency and consequently limits the number of reprogramming intermediates that can be isolated for downstream profiling. Here, we describe an improved OKSM mouse model in the context of the reverse tetracycline-controlled transactivator 3 with enhanced reprogramming efficiency (>. 9-fold) and increased numbers of reprogramming intermediate cells albeit with similar kinetics, which we believe will facilitate mechanistic studies of the reprogramming process.

AB - Reprogrammable mouse models engineered to conditionally express Oct-4, Klf-4, Sox-2 and c-Myc (OKSM) have been instrumental in dissecting molecular events underpinning the generation of induced pluripotent stem cells. However, until now these models have been reported in the context of the m2 reverse tetracycline-controlled transactivator, which results in a low reprogramming efficiency and consequently limits the number of reprogramming intermediates that can be isolated for downstream profiling. Here, we describe an improved OKSM mouse model in the context of the reverse tetracycline-controlled transactivator 3 with enhanced reprogramming efficiency (>. 9-fold) and increased numbers of reprogramming intermediate cells albeit with similar kinetics, which we believe will facilitate mechanistic studies of the reprogramming process.

UR - http://www.scopus.com/inward/record.url?scp=84969753035&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2016.05.008

DO - 10.1016/j.scr.2016.05.008

M3 - Article

VL - 17

SP - 49

EP - 53

JO - Stem Cell Research

T2 - Stem Cell Research

JF - Stem Cell Research

SN - 1873-5061

IS - 1

ER -